Tyler Stone Wealth Management Makes New $214,000 Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

Tyler Stone Wealth Management acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 360 shares of the biotechnology company’s stock, valued at approximately $214,000.

A number of other institutional investors also recently modified their holdings of the stock. Daiwa Securities Group Inc. increased its stake in Axon Enterprise by 10.9% in the third quarter. Daiwa Securities Group Inc. now owns 9,927 shares of the biotechnology company’s stock valued at $3,967,000 after purchasing an additional 973 shares in the last quarter. DRW Securities LLC bought a new stake in Axon Enterprise in the 3rd quarter valued at about $291,000. The Manufacturers Life Insurance Company raised its stake in Axon Enterprise by 0.6% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 43,643 shares of the biotechnology company’s stock worth $17,440,000 after buying an additional 276 shares during the period. Dai ichi Life Insurance Company Ltd boosted its holdings in Axon Enterprise by 63.6% in the third quarter. Dai ichi Life Insurance Company Ltd now owns 3,646 shares of the biotechnology company’s stock worth $1,457,000 after acquiring an additional 1,418 shares in the last quarter. Finally, D.A. Davidson & CO. grew its stake in Axon Enterprise by 0.3% in the third quarter. D.A. Davidson & CO. now owns 12,622 shares of the biotechnology company’s stock valued at $5,044,000 after acquiring an additional 44 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In related news, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $559.06 on Thursday. The firm has a market capitalization of $42.84 billion, a P/E ratio of 144.46, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The business’s fifty day simple moving average is $591.51 and its 200 day simple moving average is $546.76. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99.

Analyst Ratings Changes

AXON has been the topic of a number of research reports. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Robert W. Baird raised their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. TD Cowen initiated coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective for the company. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. Finally, JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $604.67.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.